After measuring the peak concentrations and area under the curve of GH and IGF-1, researchers found that CJC-1295 increased mean plasma GH concentrations by 2- to 10-fold for 6 days or more, and increased mean plasma IGF-I concentrations by 1.5- to 3-fold for 9-11 days
What's included PT-141 10mg 2 vials Ipamorelin 10mg 4 vials Kisspeptin 5mg 6 vials Melanotan-2 10mg 1 vial CJC-1295 No DAC + Ipamorelin 4 pens Female Sexual Optimization CellGenic combines Tesamorelin, Melanotan-2, Ipamorelin, Kisspeptin, PT-141, and CJC-1295/Ipamorelin for women navigating low desire and perimenopause
Golgi dysfunction further contributes to axis activation by impairing the trafficking of key nutrient transporters
Only in a limited, surrogate-marker sense
Combination Therapy and Athletic Applications Combination therapy research has explored Sermorelin together with growth hormone-releasing peptides (GHRPs) like GHRP-2, GHRP-6, or Ipamorelin, based on the concept that GHRH and GHRPs work through complementary mechanisms (GHRHR versus ghrelin receptor pathways) and can produce synergistic GH release when combined - indeed, clinical data supports enhanced GH stimulation with combination therapy versus either agent alone